OBJECTIVE: Consistent estimation of causal effects with inverse probability weighting estimators is known to rely on consistent estimation of propensity scores. To alleviate the bias expected from incorrect model specification for these nuisance parameters in observational studies, data-adaptive estimation and in particular an ensemble learning approach known as Super Learning has been proposed as an alternative to the common practice of estimation based on arbitrary model specification. While the theoretical arguments against the use of the latter haphazard estimation strategy are evident, the extent to which data-adaptive estimation can improve inferences in practice is not. Some practitioners may view bias concerns over arbitrary parametric assumptions as academic considerations that are inconsequential in practice. They may also be wary of data-adaptive estimation of the propensity scores for fear of greatly increasing estimation variability due to extreme weight values. With this report, we aim to contribute to the understanding of the potential practical consequences of the choice of estimation strategy for the propensity scores in real-world comparative effectiveness research. METHOD: We implement secondary analyses of Electronic Health Record data from a large cohort of type 2 diabetes patients to evaluate the effects of four adaptive treatment intensification strategies for glucose control (dynamic treatment regimens) on subsequent development or progression of urinary albumin excretion. Three Inverse Probability Weighting estimators are implemented using both model-based and data-adaptive estimation strategies for the propensity scores. Their practical performances for proper confounding and selection bias adjustment are compared and evaluated against results from previous randomized experiments. CONCLUSION: Results suggest both potential reduction in bias and increase in efficiency at the cost of an increase in computing time when using Super Learning to implement Inverse Probability Weighting estimators to draw causal inferences.
OBJECTIVE: Consistent estimation of causal effects with inverse probability weighting estimators is known to rely on consistent estimation of propensity scores. To alleviate the bias expected from incorrect model specification for these nuisance parameters in observational studies, data-adaptive estimation and in particular an ensemble learning approach known as Super Learning has been proposed as an alternative to the common practice of estimation based on arbitrary model specification. While the theoretical arguments against the use of the latter haphazard estimation strategy are evident, the extent to which data-adaptive estimation can improve inferences in practice is not. Some practitioners may view bias concerns over arbitrary parametric assumptions as academic considerations that are inconsequential in practice. They may also be wary of data-adaptive estimation of the propensity scores for fear of greatly increasing estimation variability due to extreme weight values. With this report, we aim to contribute to the understanding of the potential practical consequences of the choice of estimation strategy for the propensity scores in real-world comparative effectiveness research. METHOD: We implement secondary analyses of Electronic Health Record data from a large cohort of type 2 diabetespatients to evaluate the effects of four adaptive treatment intensification strategies for glucose control (dynamic treatment regimens) on subsequent development or progression of urinary albumin excretion. Three Inverse Probability Weighting estimators are implemented using both model-based and data-adaptive estimation strategies for the propensity scores. Their practical performances for proper confounding and selection bias adjustment are compared and evaluated against results from previous randomized experiments. CONCLUSION: Results suggest both potential reduction in bias and increase in efficiency at the cost of an increase in computing time when using Super Learning to implement Inverse Probability Weighting estimators to draw causal inferences.
Authors: Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán Journal: Int J Biostat Date: 2010 Impact factor: 0.968
Authors: Romain Neugebauer; Bruce Fireman; Jason A Roy; Marsha A Raebel; Gregory A Nichols; Patrick J O'Connor Journal: J Clin Epidemiol Date: 2013-08 Impact factor: 6.437
Authors: Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan Journal: Ann Intern Med Date: 2011-04-19 Impact factor: 25.391
Authors: Joan C Lo; Romain S Neugebauer; Bruce Ettinger; Malini Chandra; Rita L Hui; Susan M Ott; Christopher D Grimsrud; Monika A Izano Journal: BMC Musculoskelet Disord Date: 2020-12-03 Impact factor: 2.362
Authors: Emily B Schroeder; Romain Neugebauer; Kristi Reynolds; Julie A Schmittdiel; Linda Loes; Wendy Dyer; Noel Pimentel; Jay R Desai; Gabriela Vazquez-Benitez; P Michael Ho; Jeffrey P Anderson; Patrick J O'Connor Journal: JAMA Netw Open Date: 2021-09-01
Authors: Romain Neugebauer; Emily B Schroeder; Kristi Reynolds; Julie A Schmittdiel; Linda Loes; Wendy Dyer; Jay R Desai; Gabriela Vazquez-Benitez; P Michael Ho; Jeff P Anderson; Noel Pimentel; Patrick J O'Connor Journal: JAMA Netw Open Date: 2020-01-03
Authors: Maarten J IJzerman; Julie A Simpson; Robert K Mahar; Myra B McGuinness; Bibhas Chakraborty; John B Carlin Journal: BMC Med Res Methodol Date: 2021-02-22 Impact factor: 4.615
Authors: Monika A Izano; Joan C Lo; Annette L Adams; Bruce Ettinger; Susan M Ott; Malini Chandra; Rita L Hui; Fang Niu; Bonnie H Li; Romain S Neugebauer Journal: JAMA Netw Open Date: 2020-12-01